Toxic Injury to Muscle Tissue of Rats Following Acute Oximes Exposure

Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase react...

Full description

Saved in:
Bibliographic Details
Published inScientific reports Vol. 9; no. 1; p. 1457
Main Authors Jaćević, Vesna, Nepovimova, Eugenie, Kuča, Kamil
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 06.02.2019
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN2045-2322
2045-2322
DOI10.1038/s41598-018-37837-4

Cover

Abstract Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD 50 , 0.5 LD 50 , and 1.0 LD 50 of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD 50 of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD 50 of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD 50 and 1.0 LD 50 of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation.
AbstractList Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD 50 , 0.5 LD 50 , and 1.0 LD 50 of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD 50 of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD 50 of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD 50 and 1.0 LD 50 of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation.
Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD50, 0.5 LD50, and 1.0 LD50 of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD50 of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD50 of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD50 and 1.0 LD50 of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation.
Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD , 0.5 LD , and 1.0 LD of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD and 1.0 LD of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation.
Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD50, 0.5 LD50, and 1.0 LD50 of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD50 of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD50 of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD50 and 1.0 LD50 of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation.Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD50, 0.5 LD50, and 1.0 LD50 of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD50 of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD50 of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD50 and 1.0 LD50 of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation.
ArticleNumber 1457
Author Nepovimova, Eugenie
Jaćević, Vesna
Kuča, Kamil
Author_xml – sequence: 1
  givenname: Vesna
  orcidid: 0000-0001-5137-2638
  surname: Jaćević
  fullname: Jaćević, Vesna
  organization: National Poison Control Centre, Military Medical Academy, Faculty of Medicine of the Military Medical Academy, University of Defence, Department of Chemistry, Faculty of Science, University of Hradec Kralove
– sequence: 2
  givenname: Eugenie
  surname: Nepovimova
  fullname: Nepovimova, Eugenie
  organization: Department of Chemistry, Faculty of Science, University of Hradec Kralove
– sequence: 3
  givenname: Kamil
  surname: Kuča
  fullname: Kuča, Kamil
  email: kamil.kuca@uhk.cz
  organization: Department of Chemistry, Faculty of Science, University of Hradec Kralove
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30728420$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtvGyEUhVGVqHn-gS4qpG66mZbXDLCpFEVOGilVpMhZI8B3XKwxuDC0zr_vpE7TNIuwAYnvHM7lHKG9mCIg9I6ST5Rw9bkI2mrVEKoaLhWXjXiDDhkRbcM4Y3vPzgfotJQVmVbLtKD6LTrgRDIlGDlEs3naBo-v4qrmezwm_K0WPwCeh1Iq4NTjWzsWfJGGIf0KcYnPfB0B32zDGgqebTep1AwnaL-3Q4HTx_0Y3V3M5udfm-uby6vzs-vGCynGhi9cb50WDByTDkBq2XFCbcvAd9S1xLXacW-9XmjXS9FTpV0HoBaeeWU7foy-7Hw31a1h4SGO2Q5mk8Pa5nuTbDD_38Tw3SzTT9Pxrm2ZnAw-Phrk9KNCGc06FA_DYCOkWgxjTBOpKFUT-uEFuko1x2k8w6jsJOkkJxP1_nmipyh_f3gC2A7wOZWSoX9CKDEPTZpdk2Zq0vxp0ohJpF6IfBjtGNLDVGF4Xcp30jK9E5eQ_8V-RfUbRzqynw
CitedBy_id crossref_primary_10_3390_ijms23052596
crossref_primary_10_1016_j_etap_2019_103221
crossref_primary_10_1007_s00204_021_03098_w
crossref_primary_10_1016_j_cbi_2019_05_035
crossref_primary_10_1039_D3RA00717K
crossref_primary_10_1016_j_biopha_2023_115600
crossref_primary_10_1016_j_fct_2020_111138
crossref_primary_10_1002_adma_202101326
crossref_primary_10_3390_toxins12100643
crossref_primary_10_1016_j_cbi_2023_110658
crossref_primary_10_2174_1874104502015010017
crossref_primary_10_2174_0929867330999221014104610
crossref_primary_10_1155_2020_1720961
crossref_primary_10_1016_j_cbi_2024_111138
crossref_primary_10_1038_s41598_019_52768_4
crossref_primary_10_1186_s43141_022_00429_x
crossref_primary_10_3390_ijms21197236
Cites_doi 10.1038/nm.3869
10.1016/S0960-894X(03)00751-0
10.1113/jphysiol.2006.118265
10.1016/j.cbi.2016.04.034
10.1016/j.coph.2006.01.006
10.1039/C6TX00130K
10.2174/092986709788803088
10.1016/j.toxlet.2011.04.004
10.1016/j.yrtph.2014.12.019
10.1111/j.1742-7843.2008.00249.x
10.1080/01480540601017637
10.1016/j.imbio.2013.09.001
10.1016/j.tcb.2005.10.007
10.1186/s40360-017-0193-y
10.1590/1414-431X20165646
10.1177/0885066603258659
10.1016/j.tox.2005.06.011
10.1007/s00204-016-1827-3
10.1016/S0065-2423(04)38006-6
10.1007/s002040050100
10.1136/bjsm.37.4.284
10.1038/s41598-018-32376-4
10.1096/fj.14-270090
10.1016/j.cbi.2012.08.019
10.1002/jat.1457
10.1007/BF03033319
10.1515/aiht-2015-66-2623
10.1016/j.neuro.2016.05.006
10.3121/cmr.2007.701
10.1016/j.jab.2016.05.004
10.1016/j.toxlet.2011.04.006
10.1016/j.cbi.2012.08.014
10.3390/ijms19082370
10.1097/BOR.0000000000000108
10.1242/dev.069088
10.1023/A:1024960819430
10.1016/j.toxlet.2009.07.025
10.2174/1568026611209061775
10.1016/j.tem.2015.07.005
10.1152/ajpregu.00454.2004
10.1002/jat.1084
10.1016/S0040-4039(03)00538-0
10.1016/j.yexmp.2017.03.005
10.1016/j.tox.2005.11.003
10.1021/jm070653r
10.1016/j.tiv.2006.06.009
10.1016/j.biopha.2010.01.002
10.1084/jem.20070075
10.3390/ijms140816882
10.1038/mt.2015.97
10.1016/j.yrtph.2016.07.011
10.1002/jat.1229
10.1186/s40634-016-0051-7
10.2174/1389557514666140219103138
10.1249/00005768-199507000-00011
10.1093/chromsci/46.4.316
10.14429/dlsj.1.10733
10.1016/j.cbi.2012.10.017
10.1093/toxsci/kfp166
10.1038/nrneph.2014.133
10.1083/jcb.200212046
10.1242/dev.067587
10.1007/s00204-012-0977-1
10.1080/00032710701588531
10.1023/A:1015818821686
10.1016/S0889-857X(21)00069-7
10.1002/cphy.c100092
10.33549/physiolres.932105
10.21236/ADA398241
10.1007/978-3-0348-8958-2_19
ContentType Journal Article
Copyright The Author(s) 2019
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2019
– notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
Q9U
7X8
5PM
DOI 10.1038/s41598-018-37837-4
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni)
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

CrossRef
Publicly Available Content Database
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID PMC6365527
30728420
10_1038_s41598_018_37837_4
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBLON
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
NPM
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PUEGO
Q9U
7X8
5PM
ID FETCH-LOGICAL-c474t-3dbfab942eb27bee7976301a52ec61b50b59b3cac9d9bf74f189b6ee8dc2c8a63
IEDL.DBID M48
ISSN 2045-2322
IngestDate Thu Aug 21 18:20:44 EDT 2025
Fri Sep 05 08:57:38 EDT 2025
Tue Sep 09 14:51:37 EDT 2025
Thu Jan 02 22:58:36 EST 2025
Thu Apr 24 23:01:39 EDT 2025
Tue Jul 01 00:58:31 EDT 2025
Fri Feb 21 02:40:51 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-3dbfab942eb27bee7976301a52ec61b50b59b3cac9d9bf74f189b6ee8dc2c8a63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5137-2638
OpenAccessLink https://www.proquest.com/docview/2176706730?pq-origsite=%requestingapplication%
PMID 30728420
PQID 2176706730
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6365527
proquest_miscellaneous_2229078118
proquest_journals_2176706730
pubmed_primary_30728420
crossref_primary_10_1038_s41598_018_37837_4
crossref_citationtrail_10_1038_s41598_018_37837_4
springer_journals_10_1038_s41598_018_37837_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-02-06
PublicationDateYYYYMMDD 2019-02-06
PublicationDate_xml – month: 02
  year: 2019
  text: 2019-02-06
  day: 06
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2019
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Bajgar (CR8) 2009; 16
Schlager, Dolzine, Stewart, Wannarka, Shih (CR18) 1991; 8
Andrade (CR36) 2016; 49
Bohlmeyer, Wu, Perryman (CR50) 1994; 20
Sharma (CR21) 2016; 259
Jones, Kirsch, Wortmann, Pillinger (CR47) 2014; 26
Tidball (CR54) 2005; 288
Kuca, Bielavsky, Cabal, Kassa (CR71) 2003; 13
CR37
Jaćević (CR76) 2016; 14
CR35
Chambers, Chambers, Meek, Pringle (CR22) 2013; 203
Soukup, Jun, Tobin, Kuca (CR31) 2013; 87
Kuca, Bielavsky, Cabal, Bielavska (CR70) 2003; 44
Munoz-Canoves, Serrano (CR64) 2015; 26
Tidball (CR55) 1995; 27
Vassallo (CR45) 2009; 111
Bartosova, Kuca, Kunesova, Jun (CR33) 2006; 9
Lorke (CR28) 2007; 27
Pejchal (CR44) 2008; 103
Tidball (CR53) 2011; 1
Tidball, Wehling-Henricks (CR57) 2007; 578
Swami, Saxena, Karade, Kumar (CR38) 2016; 1
Moshiri (CR48) 2017; 20
Szinicz (CR1) 2005; 214
Sambasivan (CR67) 2011; 138
CR2
Jokanovic (CR11) 2009; 190
Bajgar (CR7) 2004; 38
Litchfield, Wilcoxon (CR75) 1949; 96
CR5
de Koning, van Grol, Noort (CR25) 2011; 206
Garattini, Perico (CR26) 2014; 10
Toumi, Best (CR56) 2003; 37
Jokanovic (CR12) 2012; 12
CR49
Masson (CR9) 2011; 206
Adamson (CR39) 2016; 80
CR46
Zhao (CR61) 2016; 30
Nežić (CR79) 2018; 8
Soukup (CR29) 2010; 64
Antonijevic (CR34) 2016; 55
Žunec (CR43) 2015; 66
Musilek (CR40) 2007; 50
Sorichter, Puschendorf, Mair (CR51) 1999; 5
McLennan (CR59) 1996; 188
Gorecki (CR14) 2016; 90
Antonijevic, Stojiljkovic (CR4) 2007; 5
Spöhrer, Thiermann, Klimmek, Eyer (CR17) 1994; 68
Sepsova (CR27) 2014; 14
Wang (CR41) 2015; 71
Sakurada (CR15) 2003; 28
Jun (CR73) 2007; 40
Radic (CR23) 2013; 203
Kovarik (CR24) 2013; 203
Arnold (CR60) 2007; 204
Kuca (CR72) 2005; 25
Kuca, Jun, Bajgar (CR13) 2007; 30
Tidball, Welc (CR58) 2015; 23
Lorke, Petroianu (CR16) 2009; 29
Chazaud (CR62) 2014; 219
Lemos (CR65) 2015; 21
Jaćević (CR77) 2017; 102
Jaćević (CR78) 2018; 19
Kuča (CR42) 2018; 19
Wiener, Hoffman (CR6) 2004; 19
Dalton (CR10) 2006; 20
Nepovimova (CR20) 2016; 5
Laumonier, Menetrey (CR52) 2016; 3
Korabecny (CR19) 2014; 14
Relaix, Zammit (CR66) 2012; 13
Calić (CR32) 2006; 219
Collins (CR68) 2006; 6
Jun (CR74) 2008; 46
Willingham (CR3) 2000; 6
Soukup (CR30) 2011; 60
Chazaud (CR63) 2003; 163
Dhawan, Rando (CR69) 2005; 15
JT Litchfield (37837_CR75) 1949; 96
37837_CR5
37837_CR2
JD Jones (37837_CR47) 2014; 26
K Kuca (37837_CR13) 2007; 30
S Sorichter (37837_CR51) 1999; 5
V Pejchal (37837_CR44) 2008; 103
J Korabecny (37837_CR19) 2014; 14
O Soukup (37837_CR30) 2011; 60
R Sharma (37837_CR21) 2016; 259
O Soukup (37837_CR31) 2013; 87
37837_CR35
37837_CR37
L Nežić (37837_CR79) 2018; 8
M Moshiri (37837_CR48) 2017; 20
S Willingham (37837_CR3) 2000; 6
J Dhawan (37837_CR69) 2005; 15
TJ Bohlmeyer (37837_CR50) 1994; 20
M Calić (37837_CR32) 2006; 219
CH Dalton (37837_CR10) 2006; 20
Z Radic (37837_CR23) 2013; 203
D Swami (37837_CR38) 2016; 1
E Antonijevic (37837_CR34) 2016; 55
JE Chambers (37837_CR22) 2013; 203
Z Kovarik (37837_CR24) 2013; 203
B Chazaud (37837_CR62) 2014; 219
W Zhao (37837_CR61) 2016; 30
V Sepsova (37837_CR27) 2014; 14
J Bajgar (37837_CR7) 2004; 38
K Kuca (37837_CR71) 2003; 13
JG Tidball (37837_CR55) 1995; 27
H Toumi (37837_CR56) 2003; 37
JG Tidball (37837_CR57) 2007; 578
EL Andrade (37837_CR36) 2016; 49
DR Lemos (37837_CR65) 2015; 21
SW Wiener (37837_CR6) 2004; 19
JG Tidball (37837_CR54) 2005; 288
O Soukup (37837_CR29) 2010; 64
D Jun (37837_CR73) 2007; 40
V Jaćević (37837_CR78) 2018; 19
L Bartosova (37837_CR33) 2006; 9
R Sambasivan (37837_CR67) 2011; 138
T Laumonier (37837_CR52) 2016; 3
DE Lorke (37837_CR16) 2009; 29
P Masson (37837_CR9) 2011; 206
U Spöhrer (37837_CR17) 1994; 68
RH Adamson (37837_CR39) 2016; 80
K Kuca (37837_CR72) 2005; 25
P Munoz-Canoves (37837_CR64) 2015; 26
M Jokanovic (37837_CR11) 2009; 190
S Žunec (37837_CR43) 2015; 66
S Garattini (37837_CR26) 2014; 10
JG Tidball (37837_CR53) 2011; 1
V Jaćević (37837_CR76) 2016; 14
E Nepovimova (37837_CR20) 2016; 5
CA Collins (37837_CR68) 2006; 6
MC de Koning (37837_CR25) 2011; 206
IS McLennan (37837_CR59) 1996; 188
K Sakurada (37837_CR15) 2003; 28
JD Vassallo (37837_CR45) 2009; 111
B Chazaud (37837_CR63) 2003; 163
K Musilek (37837_CR40) 2007; 50
V Jaćević (37837_CR77) 2017; 102
JW Schlager (37837_CR18) 1991; 8
JG Tidball (37837_CR58) 2015; 23
F Relaix (37837_CR66) 2012; 13
K Kuca (37837_CR70) 2003; 44
L Szinicz (37837_CR1) 2005; 214
37837_CR46
DE Lorke (37837_CR28) 2007; 27
37837_CR49
L Gorecki (37837_CR14) 2016; 90
L Arnold (37837_CR60) 2007; 204
M Jokanovic (37837_CR12) 2012; 12
Y Wang (37837_CR41) 2015; 71
K Kuča (37837_CR42) 2018; 19
D Jun (37837_CR74) 2008; 46
J Bajgar (37837_CR8) 2009; 16
B Antonijevic (37837_CR4) 2007; 5
References_xml – volume: 21
  start-page: 786
  year: 2015
  end-page: 794
  ident: CR65
  article-title: Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis fibro/adipogenic progenitors
  publication-title: Nat. Med.
  doi: 10.1038/nm.3869
– volume: 60
  start-page: 679
  year: 2011
  end-page: 686
  ident: CR30
  article-title: Oxime reactivators and their and effects on nicotinic receptors
  publication-title: Physiol. Res.
– ident: CR49
– volume: 13
  start-page: 3545
  year: 2003
  end-page: 3547
  ident: CR71
  article-title: Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(03)00751-0
– volume: 578
  start-page: 327
  year: 2007
  end-page: 336
  ident: CR57
  article-title: Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice
  publication-title: J. Physiol.
  doi: 10.1113/jphysiol.2006.118265
– volume: 259
  start-page: 85
  year: 2016
  end-page: 92
  ident: CR21
  article-title: Synthesis and reactivation screening of imidazolium and oximes as reactivators of sarin and VX-inhibited human acetylcholinesterase (hAChE)
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2016.04.034
– volume: 96
  start-page: 99
  year: 1949
  end-page: 113
  ident: CR75
  article-title: A simplified method of evaluating dose-effect experiments
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 20
  start-page: 845
  year: 1994
  end-page: 856
  ident: CR50
  article-title: Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis
  publication-title: Rheum. Dis.Clin. North Am.
– volume: 6
  start-page: 301
  year: 2006
  end-page: 306
  ident: CR68
  article-title: Satellite cell self-renewal
  publication-title: Curr. Opin. Pharmacol.
  doi: 10.1016/j.coph.2006.01.006
– volume: 5
  start-page: 1012
  year: 2016
  end-page: 1016
  ident: CR20
  article-title: A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication
  publication-title: Toxicol. Res.
  doi: 10.1039/C6TX00130K
– volume: 16
  start-page: 2977
  year: 2009
  end-page: 2986
  ident: CR8
  article-title: Chemical aspects of pharmacological prophylaxis against nerve agent poisoning
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986709788803088
– volume: 20
  start-page: 256
  year: 2017
  end-page: 259
  ident: CR48
  article-title: Injury to skeletal muscle of mice following acute and sub-acute pregabalin exposure
  publication-title: Iran. J. Basic Med. Sci.
– volume: 206
  start-page: 54
  year: 2011
  end-page: 59
  ident: CR25
  article-title: Peripheral site ligand conjugation to a non-quaternary oxime enhances reactivation of nerve agent-inhibited human acetylcholinesterase
  publication-title: Toxicol Lett.
  doi: 10.1016/j.toxlet.2011.04.004
– volume: 71
  start-page: 205
  year: 2015
  end-page: 212
  ident: CR41
  article-title: Relationship between lethal toxicity in oral administration and injection to mice: Effect of exposure routes
  publication-title: Reg. Toxicol. Pharma.
  doi: 10.1016/j.yrtph.2014.12.019
– volume: 103
  start-page: 119
  year: 2008
  end-page: 123
  ident: CR44
  article-title: The Influence of Acetylcholinesterase Reactivators on Selected Hepatic Functions in Rats
  publication-title: Basic Clinic. Pharmacol. Toxicol.
  doi: 10.1111/j.1742-7843.2008.00249.x
– ident: CR35
– volume: 30
  start-page: 31
  year: 2007
  end-page: 40
  ident: CR13
  article-title: Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity
  publication-title: Drug Chem. Toxicol.
  doi: 10.1080/01480540601017637
– volume: 219
  start-page: 172
  year: 2014
  end-page: 178
  ident: CR62
  article-title: Macrophages: supportive cells for tissue repair andregeneration
  publication-title: Immunobiol.
  doi: 10.1016/j.imbio.2013.09.001
– volume: 15
  start-page: 666
  year: 2005
  end-page: 673
  ident: CR69
  article-title: Stem cells in postnatal myogenesis: molecularmechanisms of satellite cell quiescence, activation and replenishment
  publication-title: Trends Cell. Biol.
  doi: 10.1016/j.tcb.2005.10.007
– volume: 19
  start-page: 2
  year: 2018
  end-page: 10
  ident: CR42
  article-title: A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase
  publication-title: BC Pharmacol. Toxicol.
  doi: 10.1186/s40360-017-0193-y
– volume: 49
  start-page: e5646
  year: 2016
  ident: CR36
  article-title: Non-clinical studies in the process of new dru development – Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies
  publication-title: Braz. J. Med. Biol. Res.
  doi: 10.1590/1414-431X20165646
– volume: 19
  start-page: 22
  year: 2004
  end-page: 37
  ident: CR6
  article-title: Nerve Agents: A Comprehensive
  publication-title: Review J. Intens. Care. Med.
  doi: 10.1177/0885066603258659
– volume: 214
  start-page: 167
  year: 2005
  end-page: 81
  ident: CR1
  article-title: History of chemical and biological warfare agents
  publication-title: Toxicol.
  doi: 10.1016/j.tox.2005.06.011
– volume: 90
  start-page: 2831
  year: 2016
  end-page: 2859
  ident: CR14
  article-title: SAR study to find optimal cholinesterase reactivator against organophosphorus nerve agents and pesticides
  publication-title: Arch. Toxicol.
  doi: 10.1007/s00204-016-1827-3
– volume: 38
  start-page: 151
  year: 2004
  end-page: 216
  ident: CR7
  article-title: Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment
  publication-title: Adv. Clin. Chem.
  doi: 10.1016/S0065-2423(04)38006-6
– volume: 68
  start-page: 480
  year: 1994
  end-page: 489
  ident: CR17
  article-title: Pharmacokinetics of the oximes HI 6 and HLö 7 in a dog after i.m. injection with newly developed dry/wet autoinjectors
  publication-title: Arch. Toxicol.
  doi: 10.1007/s002040050100
– ident: CR46
– volume: 37
  start-page: 284
  year: 2003
  end-page: 286
  ident: CR56
  article-title: The inflammatory response: friend or enemy for muscle injury?
  publication-title: Br. J. Sports Med.
  doi: 10.1136/bjsm.37.4.284
– volume: 8
  year: 2018
  ident: CR79
  article-title: Simvastatin protects cardiomyocytes against endotoxin-induced apoptosis and up-regulates survivin/NF-κB/p65 expression
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-32376-4
– volume: 30
  start-page: 380
  year: 2016
  end-page: 393
  ident: CR61
  article-title: CX3CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions
  publication-title: FASEB J
  doi: 10.1096/fj.14-270090
– volume: 203
  start-page: 77
  year: 2013
  end-page: 80
  ident: CR24
  article-title: Centrally acting oximes in reactivation of tabun-phosphoramidite AChE
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2012.08.019
– volume: 29
  start-page: 459
  year: 2009
  end-page: 469
  ident: CR16
  article-title: Minireview: does testing of oximes help predict their action after paraoxon exposure?
  publication-title: J. Appl. Toxicol.
  doi: 10.1002/jat.1457
– volume: 9
  start-page: 291
  year: 2006
  end-page: 296
  ident: CR33
  article-title: The acute toxicity of acetylcholinesterase reactivators in mice in relation to their structure
  publication-title: Neurotox. Res.
  doi: 10.1007/BF03033319
– volume: 66
  start-page: 129
  year: 2015
  end-page: 134
  ident: CR43
  article-title: Comparative determination of the efficacy of bispyridinium oximes in paraoxon poisoning
  publication-title: Arh. Hig. Rada Toksikol.
  doi: 10.1515/aiht-2015-66-2623
– volume: 55
  start-page: 33
  year: 2016
  end-page: 39
  ident: CR34
  article-title: Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitor
  publication-title: Neurotoxicol.
  doi: 10.1016/j.neuro.2016.05.006
– volume: 5
  start-page: 71
  year: 2007
  end-page: 82
  ident: CR4
  article-title: Unequal efficacy of pyridinium oximes in acute organophosphate poisoning
  publication-title: Clinic. Med. Res.
  doi: 10.3121/cmr.2007.701
– volume: 14
  start-page: 285
  year: 2016
  end-page: 297
  ident: CR76
  article-title: Effects of fullerenol nanoparticles and amifostine on radiation-induced tissue damages: Histopathological analysis
  publication-title: J. Appl. Biomed.
  doi: 10.1016/j.jab.2016.05.004
– ident: CR5
– volume: 206
  start-page: 5
  year: 2011
  end-page: 13
  ident: CR9
  article-title: Evolution of and perspectives on therapeutic approaches to nerve agent poisoning
  publication-title: Toxicol. Lett.
  doi: 10.1016/j.toxlet.2011.04.006
– volume: 203
  start-page: 67
  year: 2013
  end-page: 71
  ident: CR23
  article-title: Mechanism of interaction of novel uncharged, centrally active reactivators with OP-hAChE conjugates
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2012.08.014
– volume: 19
  start-page: 2370
  year: 2018
  ident: CR78
  article-title: The efficacy of amifostine against multiple-dose doxorubicin-induced toxicity in rats
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms19082370
– volume: 26
  start-page: 697
  year: 2014
  end-page: 703
  ident: CR47
  article-title: The causes of drug-induced muscle toxicity
  publication-title: Curr. Opin. Rheumatol.
  doi: 10.1097/BOR.0000000000000108
– volume: 13
  start-page: 2845
  year: 2012
  end-page: 2856
  ident: CR66
  article-title: Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns to centre stage
  publication-title: Develop.
  doi: 10.1242/dev.069088
– volume: 28
  start-page: 1401
  year: 2003
  end-page: 1407
  ident: CR15
  article-title: Pralidoximeiodide (2-pAM) penetrates across the blood-brain barrier
  publication-title: Neurochem. Res.
  doi: 10.1023/A:1024960819430
– volume: 190
  start-page: 107
  year: 2009
  end-page: 115
  ident: CR11
  article-title: Medical treatment of acute poisoning with organophosphorus and carbamate pesticides
  publication-title: Toxicol. Lett.
  doi: 10.1016/j.toxlet.2009.07.025
– volume: 12
  start-page: 1775
  year: 2012
  end-page: 1789
  ident: CR12
  article-title: Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: a review of recent data
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/1568026611209061775
– volume: 26
  start-page: 449
  year: 2015
  end-page: 450
  ident: CR64
  article-title: Macrophages decide between regenerationand fibrosis in muscle
  publication-title: Trends Endocrinol. Metab.
  doi: 10.1016/j.tem.2015.07.005
– volume: 288
  start-page: R345
  year: 2005
  end-page: R353
  ident: CR54
  article-title: Inflammatory processes in muscle injury and repair
  publication-title: Am. J.Physiol. Regul. Integr. Comp. Physiol.
  doi: 10.1152/ajpregu.00454.2004
– volume: 6
  start-page: 1
  year: 2000
  end-page: 7
  ident: CR3
  article-title: Military Role in U.S. Response to Terrorism Remains Unclear
  publication-title: Nat. Def. Mag.
– volume: 25
  start-page: 491
  year: 2005
  end-page: 495
  ident: CR72
  article-title: Effective bisquaternary reactivators of tabun-inhibited AChE
  publication-title: J. Appl Toxicol.
  doi: 10.1002/jat.1084
– ident: CR2
– ident: CR37
– volume: 44
  start-page: 3123
  year: 2003
  end-page: 3125
  ident: CR70
  article-title: Synthesis of a potential reactivator of acetylcholinesterase-1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)propane dibromide
  publication-title: Tetrahed. Lett.
  doi: 10.1016/S0040-4039(03)00538-0
– volume: 102
  start-page: 360
  year: 2017
  end-page: 369
  ident: CR77
  article-title: Fullerenol nanoparticles prevent doxorubicin-induced acute hepatotoxicity in rats
  publication-title: Exp. Mol. Path.
  doi: 10.1016/j.yexmp.2017.03.005
– volume: 219
  start-page: 85
  year: 2006
  end-page: 96
  ident: CR32
  article-title: and evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, the effect on tabun- and soman-poisoned mice and their cytotoxicity
  publication-title: Toxicol.
  doi: 10.1016/j.tox.2005.11.003
– volume: 50
  start-page: 5514
  year: 2007
  end-page: 5548
  ident: CR40
  article-title: Design of a potent reactivator of tabun-inhibited acetylcholinesterase-synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203)
  publication-title: J. Med. Chem.
  doi: 10.1021/jm070653r
– volume: 20
  start-page: 1532
  year: 2006
  end-page: 1536
  ident: CR10
  article-title: Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methylphosphonothioate)through the pig, human and guinea pig skin
  publication-title: Toxicol. In Vitro
  doi: 10.1016/j.tiv.2006.06.009
– volume: 64
  start-page: 541
  year: 2010
  end-page: 545
  ident: CR29
  article-title: Novel acetylcholinesterase reactivator K112 and its cholinergic properties
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2010.01.002
– volume: 204
  start-page: 1057
  year: 2007
  end-page: 1069
  ident: CR60
  article-title: Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20070075
– volume: 14
  start-page: 16882
  year: 2014
  end-page: 16900
  ident: CR27
  article-title: Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms140816882
– volume: 23
  start-page: 1134
  year: 2015
  end-page: 1135
  ident: CR58
  article-title: Macrophage-derived IGF-1 is a potent coordinator of myogenesis and inflammation in regenerating muscle
  publication-title: Mol. Ther.
  doi: 10.1038/mt.2015.97
– volume: 80
  start-page: 274
  year: 2016
  end-page: 276
  ident: CR39
  article-title: The acute lethal dose 50 (LD ) of caffeine in albino rats
  publication-title: Reg. Toxicol. Pharmacol.
  doi: 10.1016/j.yrtph.2016.07.011
– volume: 27
  start-page: 482
  year: 2007
  end-page: 490
  ident: CR28
  article-title: Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime
  publication-title: J. Appl. Toxicol.
  doi: 10.1002/jat.1229
– volume: 3
  start-page: 1
  year: 2016
  end-page: 9
  ident: CR52
  article-title: Muscle injuries and strategies for improving their repair
  publication-title: J. Exp. Orthop.
  doi: 10.1186/s40634-016-0051-7
– volume: 14
  start-page: 215
  year: 2014
  end-page: 221
  ident: CR19
  article-title: From pyridinium-based to centrally active acetylcholinesterase reactivators
  publication-title: Mini. Rev. Med. Chem.
  doi: 10.2174/1389557514666140219103138
– volume: 188
  start-page: 17
  year: 1996
  end-page: 28
  ident: CR59
  article-title: Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions
  publication-title: J. Anat.
– volume: 27
  start-page: 1022
  year: 1995
  end-page: 1032
  ident: CR55
  article-title: Inflammatory cell response to acute muscle injury
  publication-title: Med. Sci. Sports Exerc.
  doi: 10.1249/00005768-199507000-00011
– volume: 46
  start-page: 316
  year: 2008
  end-page: 319
  ident: CR74
  article-title: TLC Analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate
  publication-title: J. Chromat. Sci.
  doi: 10.1093/chromsci/46.4.316
– volume: 1
  start-page: 149
  year: 2016
  end-page: 154
  ident: CR38
  article-title: Comparative toxicity of pyridinium acetamide derivatives in human cell lines and their acute toxicity in Swiss albino mice
  publication-title: Def. Life Sci. J.
  doi: 10.14429/dlsj.1.10733
– volume: 203
  start-page: 135
  year: 2013
  end-page: 138
  ident: CR22
  article-title: Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2012.10.017
– volume: 111
  start-page: 402
  year: 2009
  end-page: 412
  ident: CR45
  article-title: Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/kfp166
– volume: 10
  start-page: 602
  year: 2014
  end-page: 610
  ident: CR26
  article-title: Drug development: how academia, industry and authorities interact
  publication-title: Nat. Rev. Nephrol.
  doi: 10.1038/nrneph.2014.133
– volume: 163
  start-page: 1133
  year: 2003
  end-page: 1143
  ident: CR63
  article-title: Satellite cells attract monocytes and usemacrophages as a support to escape apoptosis and enhance muscle growth
  publication-title: J. Cell. Biol.
  doi: 10.1083/jcb.200212046
– volume: 138
  start-page: 3647
  year: 2011
  end-page: 3656
  ident: CR67
  article-title: Pax7-expressing satellitecells are indispensable for adult skeletal muscle regeneration
  publication-title: Develop.
  doi: 10.1242/dev.067587
– volume: 87
  start-page: 711
  year: 2013
  end-page: 719
  ident: CR31
  article-title: The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors
  publication-title: Arch Toxicol.
  doi: 10.1007/s00204-012-0977-1
– volume: 5
  start-page: 5
  year: 1999
  end-page: 21
  ident: CR51
  article-title: Skeletal muscle injury induced by eccentric muscle action: Muscle proteins as markers of muscle fibre injury
  publication-title: Exerc. Immunol. Rev.
– volume: 40
  start-page: 2783
  year: 2007
  end-page: 2787
  ident: CR73
  article-title: HPLC analysis of HI‐6 dichloride and dimethanesulfonate-antidotes against nerve agents and organophosphorus pesticides
  publication-title: Analyt. Lett.
  doi: 10.1080/00032710701588531
– volume: 1
  start-page: 2029
  year: 2011
  end-page: 2062
  ident: CR53
  article-title: Mechanisms of muscle injury, repair, and regeneration
  publication-title: Compr. Physiol.
– volume: 8
  start-page: 1191
  year: 1991
  end-page: 1194
  ident: CR18
  article-title: Operation evaluation of three commercial configurations of atropine/HI-6 wet/dry autoinjectors
  publication-title: Pharm. Res.
  doi: 10.1023/A:1015818821686
– volume: 20
  start-page: 845
  year: 1994
  ident: 37837_CR50
  publication-title: Rheum. Dis.Clin. North Am.
  doi: 10.1016/S0889-857X(21)00069-7
– volume: 68
  start-page: 480
  year: 1994
  ident: 37837_CR17
  publication-title: Arch. Toxicol.
  doi: 10.1007/s002040050100
– volume: 12
  start-page: 1775
  year: 2012
  ident: 37837_CR12
  publication-title: Curr. Top. Med. Chem.
  doi: 10.2174/1568026611209061775
– volume: 16
  start-page: 2977
  year: 2009
  ident: 37837_CR8
  publication-title: Curr. Med. Chem.
  doi: 10.2174/092986709788803088
– ident: 37837_CR49
– volume: 5
  start-page: 5
  year: 1999
  ident: 37837_CR51
  publication-title: Exerc. Immunol. Rev.
– volume: 25
  start-page: 491
  year: 2005
  ident: 37837_CR72
  publication-title: J. Appl Toxicol.
  doi: 10.1002/jat.1084
– volume: 26
  start-page: 697
  year: 2014
  ident: 37837_CR47
  publication-title: Curr. Opin. Rheumatol.
  doi: 10.1097/BOR.0000000000000108
– volume: 6
  start-page: 301
  year: 2006
  ident: 37837_CR68
  publication-title: Curr. Opin. Pharmacol.
  doi: 10.1016/j.coph.2006.01.006
– volume: 6
  start-page: 1
  year: 2000
  ident: 37837_CR3
  publication-title: Nat. Def. Mag.
– volume: 49
  start-page: e5646
  year: 2016
  ident: 37837_CR36
  publication-title: Braz. J. Med. Biol. Res.
  doi: 10.1590/1414-431X20165646
– volume: 20
  start-page: 1532
  year: 2006
  ident: 37837_CR10
  publication-title: Toxicol. In Vitro
  doi: 10.1016/j.tiv.2006.06.009
– ident: 37837_CR35
– volume: 1
  start-page: 149
  year: 2016
  ident: 37837_CR38
  publication-title: Def. Life Sci. J.
  doi: 10.14429/dlsj.1.10733
– volume: 5
  start-page: 71
  year: 2007
  ident: 37837_CR4
  publication-title: Clinic. Med. Res.
  doi: 10.3121/cmr.2007.701
– volume: 29
  start-page: 459
  year: 2009
  ident: 37837_CR16
  publication-title: J. Appl. Toxicol.
  doi: 10.1002/jat.1457
– volume: 55
  start-page: 33
  year: 2016
  ident: 37837_CR34
  publication-title: Neurotoxicol.
  doi: 10.1016/j.neuro.2016.05.006
– volume: 71
  start-page: 205
  year: 2015
  ident: 37837_CR41
  publication-title: Reg. Toxicol. Pharma.
  doi: 10.1016/j.yrtph.2014.12.019
– volume: 138
  start-page: 3647
  year: 2011
  ident: 37837_CR67
  publication-title: Develop.
  doi: 10.1242/dev.067587
– volume: 1
  start-page: 2029
  year: 2011
  ident: 37837_CR53
  publication-title: Compr. Physiol.
  doi: 10.1002/cphy.c100092
– volume: 163
  start-page: 1133
  year: 2003
  ident: 37837_CR63
  publication-title: J. Cell. Biol.
  doi: 10.1083/jcb.200212046
– volume: 204
  start-page: 1057
  year: 2007
  ident: 37837_CR60
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20070075
– volume: 30
  start-page: 380
  year: 2016
  ident: 37837_CR61
  publication-title: FASEB J
  doi: 10.1096/fj.14-270090
– volume: 9
  start-page: 291
  year: 2006
  ident: 37837_CR33
  publication-title: Neurotox. Res.
  doi: 10.1007/BF03033319
– volume: 37
  start-page: 284
  year: 2003
  ident: 37837_CR56
  publication-title: Br. J. Sports Med.
  doi: 10.1136/bjsm.37.4.284
– volume: 203
  start-page: 135
  year: 2013
  ident: 37837_CR22
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2012.10.017
– volume: 203
  start-page: 67
  year: 2013
  ident: 37837_CR23
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2012.08.014
– volume: 80
  start-page: 274
  year: 2016
  ident: 37837_CR39
  publication-title: Reg. Toxicol. Pharmacol.
  doi: 10.1016/j.yrtph.2016.07.011
– volume: 23
  start-page: 1134
  year: 2015
  ident: 37837_CR58
  publication-title: Mol. Ther.
  doi: 10.1038/mt.2015.97
– volume: 259
  start-page: 85
  year: 2016
  ident: 37837_CR21
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2016.04.034
– volume: 103
  start-page: 119
  year: 2008
  ident: 37837_CR44
  publication-title: Basic Clinic. Pharmacol. Toxicol.
  doi: 10.1111/j.1742-7843.2008.00249.x
– volume: 13
  start-page: 2845
  year: 2012
  ident: 37837_CR66
  publication-title: Develop.
  doi: 10.1242/dev.069088
– volume: 50
  start-page: 5514
  year: 2007
  ident: 37837_CR40
  publication-title: J. Med. Chem.
  doi: 10.1021/jm070653r
– volume: 188
  start-page: 17
  year: 1996
  ident: 37837_CR59
  publication-title: J. Anat.
– volume: 30
  start-page: 31
  year: 2007
  ident: 37837_CR13
  publication-title: Drug Chem. Toxicol.
  doi: 10.1080/01480540601017637
– ident: 37837_CR2
– volume: 87
  start-page: 711
  year: 2013
  ident: 37837_CR31
  publication-title: Arch Toxicol.
  doi: 10.1007/s00204-012-0977-1
– volume: 96
  start-page: 99
  year: 1949
  ident: 37837_CR75
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 60
  start-page: 679
  year: 2011
  ident: 37837_CR30
  publication-title: Physiol. Res.
  doi: 10.33549/physiolres.932105
– ident: 37837_CR5
  doi: 10.21236/ADA398241
– volume: 214
  start-page: 167
  year: 2005
  ident: 37837_CR1
  publication-title: Toxicol.
  doi: 10.1016/j.tox.2005.06.011
– volume: 46
  start-page: 316
  year: 2008
  ident: 37837_CR74
  publication-title: J. Chromat. Sci.
  doi: 10.1093/chromsci/46.4.316
– volume: 3
  start-page: 1
  year: 2016
  ident: 37837_CR52
  publication-title: J. Exp. Orthop.
  doi: 10.1186/s40634-016-0051-7
– volume: 288
  start-page: R345
  year: 2005
  ident: 37837_CR54
  publication-title: Am. J.Physiol. Regul. Integr. Comp. Physiol.
  doi: 10.1152/ajpregu.00454.2004
– ident: 37837_CR46
  doi: 10.1007/978-3-0348-8958-2_19
– volume: 203
  start-page: 77
  year: 2013
  ident: 37837_CR24
  publication-title: Chem. Biol. Interact.
  doi: 10.1016/j.cbi.2012.08.019
– volume: 14
  start-page: 215
  year: 2014
  ident: 37837_CR19
  publication-title: Mini. Rev. Med. Chem.
  doi: 10.2174/1389557514666140219103138
– volume: 66
  start-page: 129
  year: 2015
  ident: 37837_CR43
  publication-title: Arh. Hig. Rada Toksikol.
  doi: 10.1515/aiht-2015-66-2623
– volume: 111
  start-page: 402
  year: 2009
  ident: 37837_CR45
  publication-title: Toxicol. Sci.
  doi: 10.1093/toxsci/kfp166
– volume: 90
  start-page: 2831
  year: 2016
  ident: 37837_CR14
  publication-title: Arch. Toxicol.
  doi: 10.1007/s00204-016-1827-3
– volume: 13
  start-page: 3545
  year: 2003
  ident: 37837_CR71
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/S0960-894X(03)00751-0
– volume: 10
  start-page: 602
  year: 2014
  ident: 37837_CR26
  publication-title: Nat. Rev. Nephrol.
  doi: 10.1038/nrneph.2014.133
– ident: 37837_CR37
– volume: 14
  start-page: 16882
  year: 2014
  ident: 37837_CR27
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms140816882
– volume: 27
  start-page: 482
  year: 2007
  ident: 37837_CR28
  publication-title: J. Appl. Toxicol.
  doi: 10.1002/jat.1229
– volume: 190
  start-page: 107
  year: 2009
  ident: 37837_CR11
  publication-title: Toxicol. Lett.
  doi: 10.1016/j.toxlet.2009.07.025
– volume: 40
  start-page: 2783
  year: 2007
  ident: 37837_CR73
  publication-title: Analyt. Lett.
  doi: 10.1080/00032710701588531
– volume: 26
  start-page: 449
  year: 2015
  ident: 37837_CR64
  publication-title: Trends Endocrinol. Metab.
  doi: 10.1016/j.tem.2015.07.005
– volume: 219
  start-page: 172
  year: 2014
  ident: 37837_CR62
  publication-title: Immunobiol.
  doi: 10.1016/j.imbio.2013.09.001
– volume: 27
  start-page: 1022
  year: 1995
  ident: 37837_CR55
  publication-title: Med. Sci. Sports Exerc.
  doi: 10.1249/00005768-199507000-00011
– volume: 21
  start-page: 786
  year: 2015
  ident: 37837_CR65
  publication-title: Nat. Med.
  doi: 10.1038/nm.3869
– volume: 64
  start-page: 541
  year: 2010
  ident: 37837_CR29
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2010.01.002
– volume: 20
  start-page: 256
  year: 2017
  ident: 37837_CR48
  publication-title: Iran. J. Basic Med. Sci.
– volume: 8
  year: 2018
  ident: 37837_CR79
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-32376-4
– volume: 19
  start-page: 2370
  year: 2018
  ident: 37837_CR78
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms19082370
– volume: 206
  start-page: 54
  year: 2011
  ident: 37837_CR25
  publication-title: Toxicol Lett.
  doi: 10.1016/j.toxlet.2011.04.004
– volume: 5
  start-page: 1012
  year: 2016
  ident: 37837_CR20
  publication-title: Toxicol. Res.
  doi: 10.1039/C6TX00130K
– volume: 44
  start-page: 3123
  year: 2003
  ident: 37837_CR70
  publication-title: Tetrahed. Lett.
  doi: 10.1016/S0040-4039(03)00538-0
– volume: 102
  start-page: 360
  year: 2017
  ident: 37837_CR77
  publication-title: Exp. Mol. Path.
  doi: 10.1016/j.yexmp.2017.03.005
– volume: 19
  start-page: 22
  year: 2004
  ident: 37837_CR6
  publication-title: Review J. Intens. Care. Med.
  doi: 10.1177/0885066603258659
– volume: 28
  start-page: 1401
  year: 2003
  ident: 37837_CR15
  publication-title: Neurochem. Res.
  doi: 10.1023/A:1024960819430
– volume: 15
  start-page: 666
  year: 2005
  ident: 37837_CR69
  publication-title: Trends Cell. Biol.
  doi: 10.1016/j.tcb.2005.10.007
– volume: 38
  start-page: 151
  year: 2004
  ident: 37837_CR7
  publication-title: Adv. Clin. Chem.
  doi: 10.1016/S0065-2423(04)38006-6
– volume: 19
  start-page: 2
  year: 2018
  ident: 37837_CR42
  publication-title: BC Pharmacol. Toxicol.
  doi: 10.1186/s40360-017-0193-y
– volume: 206
  start-page: 5
  year: 2011
  ident: 37837_CR9
  publication-title: Toxicol. Lett.
  doi: 10.1016/j.toxlet.2011.04.006
– volume: 219
  start-page: 85
  year: 2006
  ident: 37837_CR32
  publication-title: Toxicol.
  doi: 10.1016/j.tox.2005.11.003
– volume: 578
  start-page: 327
  year: 2007
  ident: 37837_CR57
  publication-title: J. Physiol.
  doi: 10.1113/jphysiol.2006.118265
– volume: 8
  start-page: 1191
  year: 1991
  ident: 37837_CR18
  publication-title: Pharm. Res.
  doi: 10.1023/A:1015818821686
– volume: 14
  start-page: 285
  year: 2016
  ident: 37837_CR76
  publication-title: J. Appl. Biomed.
  doi: 10.1016/j.jab.2016.05.004
SSID ssj0000529419
Score 2.3572614
Snippet Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1457
SubjectTerms 14/63
64/60
692/4017
692/499
Animal tissues
Cholinesterase
Degeneration
Diaphragm
Drug dosages
Edema
Humanities and Social Sciences
Morphology
Mortality
multidisciplinary
Muscles
Obidoxime
Oximes
Poisoning
Science
Science (multidisciplinary)
Toxicity
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZNQiGX0KQvNw8U6K0VsWxZj1MJZZe0kAbKBvZm9KQJxd7WXrL99xnZXodtSM4aIWs-j2Y0o5lB6COoVJO7IiWBSk9YkAVRmaakoIJaaRhPXXQNXP7gF9fs-7yYDw63ZnhWuT4Tu4Pa1Tb6yM_AdOYidlVJvyz-kNg1KkZXhxYaW2iHgiUSWzeIuRh9LDGKxagacmXSXJ41oK9iThmVIFlwNyNsUx89MjIfv5X8L2Da6aHpK7Q3GJD4vEd8H73w1QF62beU_PcaTWb16sbib9UtMAu3Nb5cNkCHZx2DcR3wT902eArw13ewAD63y9bjq1VMBcGT1aKOLsM36Ho6mX29IEOrBGKZYC3JnQnaKJbBRVkY7wVYGSC6usi85dQUqSmUya22yikTBANklOHeS2czKzXP36Ltqq78e4S1C95wboWHq1kWmMmkC4FRp41XRqgE0TXDSjvUEY_tLH6XXTw7l2XP5BKYXHZMLlmCPo1zFn0VjWepj9Y4lINENeUD_gk6HYdBFmKAQ1e-XgJNLF4fU2dlgt71sI3LwVkGmjiD2WID0JEg1tneHKlufnX1tnnOY526BH1eQ__wWU_v4sPzuzhEu2B7qe4BOD9C2-3fpT8G-6Y1J91PfA8LGfhn
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature OA Free Journals
  dbid: C6C
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEB9qRehLsdXW1VYi-KaLm91sPh5LuaMWqiBX6NuSZBNakd3S28Pzv3eS_ZCzteDzTkh2JsnMZGZ-A_AeVaop6jJLPZUuZV6Wqco1TUsqqJWG8awOTwMXX_jZJTu_Kq-2IB9rYWLSfoS0jNf0mB32aYmKJhSDUYlHAp2qlD2Bp1KgtgwBWn46vauEyBWjaqiPyQr5wNBNHXTPsLyfH_lXkDTqnvlz2B2MRnLSL3MPtlyzD8_6NpK_XsBs0a5vLPncfEcGka4lF6sl0pFFZCppPfmmuyWZo8jbnzgBObGrzpGv61D-QWbr2zY8E76Ey_lscXqWDu0RUssE69KiNl4bxXJ0joVxTqBlgcdVl7mznJoyM6UyhdVW1cp4wVAaynDnZG1zKzUvDmC7aRv3CoiuvTOcW-HQHcs9M7msvWe01sYpI1QCdGRYZQfs8NDC4kcVY9iFrHomV8jkKjK5Ygl8mMbc9sgZj1IfjXKohlO0rNBd4iJ00skSeDd9xv0fghq6ce0KaQJgfSiXlQkc9mKbpsP7C7VvjqPFhkAngoCtvfmlubmOGNu84AGbLoGPo-j_LOvff_H6_8jfwA7aXyomgfMj2O7uVu4YbZzOvI2b-jcg9fZe
  priority: 102
  providerName: Springer Nature
Title Toxic Injury to Muscle Tissue of Rats Following Acute Oximes Exposure
URI https://link.springer.com/article/10.1038/s41598-018-37837-4
https://www.ncbi.nlm.nih.gov/pubmed/30728420
https://www.proquest.com/docview/2176706730
https://www.proquest.com/docview/2229078118
https://pubmed.ncbi.nlm.nih.gov/PMC6365527
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw8LQPgfaCxucyRmUk3iBQJ44_HhDqqlaj0gYardS3KHYcsWlKtjUV3b_n7CSFsY2nSPFZdu4jd-fz3QG8Q5Wq4zzphwWVNmSFTEIVZTRMqKBGasb7uTsaOD7hRzM2mSfzDejaHbUIXNzr2rl-UrPri4-rq5svKPCfm5Rx-WmBSsglilGJ4oIOV8g2YdvHi9xVvtbcb2p9R4pR1ebO3D91Bx4j2-NP23UA_1tV3bE_716j_CeW6lXUeBeetLYlGTTM8BQ2bPkMHjXdJm-ew2harc4M-VqeIx5JXZHj5QLhyNTjnlQFOc3qBRkjZ1S_cAEyMMvakm8rlyVCRqvLyp0mvoDZeDQdHoVtF4XQMMHqMM51kWnFIvShhbZWoAGCUp0lkTWc6qSvE6VjkxmVK10IhkRTmlsrcxMZmfH4JWyVVWn3gGR5YTXnRlj02qKC6UjmRcFonmmrtFAB0A5hqWlLjLtOFxepD3XHMm3wnSK-U4_vlAXwfj3nsimw8V_og44OaccrKXpVXLiGO_0A3q6HUUxc7CMrbbVEGFfX3mXVygBeNWRbL9fROwBxi6BrAFeC-_ZIefbTl-LmMXcl7AL40JH-z7Ye_or9B7fwGnbQIlP-Wjg_gK36emnfoNVT6x5sirnowfZgMPkxwefh6OT7Kb4d8mHPnyT0PLP_BgHlAWE
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFS2QnBBvAkUMBKcIGoejmMfKlRgV7u0u6BqK_UW_IooQslCsur25_g2xnlstVT01rPHcTwPz3jGMwPwGlWqik0S-HnIrU9znvgikqGfhGmouaIsMM41MJ2x8TH9fJKcbMGfPhfGPavsz8TmoDaldj7yXTSdWeq6qgTvF7981zXKRVf7Fhqya61g9poSY11ix4E9P8MrXLU3-YT0fhNFo-H849jvugz4mqa09mOjcqkEjfCOmSprU1TQyPUyiaxmoUoClQgVa6mFESpPKW5KKGYtNzrSXLIYv3sDtqlzoAxg-8Nw9vVo7eVxcTQaii5bJ4j5boUa02W1hRxlG2-HPt3UiJfM3MuvNf8J2TaacHQX7nQmLNlvee4ebNniPtxsm1qeP4DhvFydajIpfiC5SF2S6bJCODJvSEzKnBzJuiIjZMDyDBcg-3pZW_Jl5ZJRyHC1KJ3T8iEcXwsaH8GgKAv7BIg0uVWM6dTi5TDKqYq4yXMaGqmsUKnwIOwRlumukrlrqPEzayLqMc9aJGeI5KxBckY9eLues2jreFwJvdPTIetkusouONCDV-thlEYXYpGFLZcI48rnu-Rd7sHjlmzr5fA0RVsgwtnpBkHXAK7S9-ZIcfq9qfjNYuYq5Xnwrif9xW_9fxdPr97FS7g1nk8Ps8PJ7OAZ3EZLUDTP0dkODOrfS_scra1avehYmsC365aiv8fZPhA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKQFwQb1JKMRKcINo8HD8OCFXtrrqUFoS20t5C7NiiCCVLk1W3v8bXMc6rWip669njOJ6HZ8bjmQF4gypVxXkS-DYUxqdWJL6MstBPQh5qoSgLcnc1cHTMDk7op3ky34A_fS6Me1bZn4nNQZ2X2t2Rj9B0Ztx1VQlGtnsW8XV_8nHx23cdpFyktW-n0bLIobk4R_et-jDdR1q_jaLJeLZ34HcdBnxNOa39OFc2U5JG6F9yZQxH5YwcnyWR0SxUSaASqWKdaZlLZTnFDUnFjBG5jrTIWIzfvQW3eUypaxvB53y433ERNBrKLk8niMWoQl3p8tlCgVKNfqFP13XhFQP36jvNf4K1jQ6cPID7nfFKdltuewgbpngEd9p2lhePYTwrV6eaTIufSChSl-RoWSEcmTXEJaUl37K6IhNkvfIcFyC7elkb8mXl0lDIeLUo3XXlEzi5ESQ-hc2iLMxzIFlujWJMc4NuYWSpikRuLQ3zTBmpuPQg7BGW6q6GuWul8SttYumxSFskp4jktEFySj14N8xZtBU8roXe7umQdtJcpZe858HrYRjl0AVXssKUS4RxhfNd2q7w4FlLtmE5PEfRCohwNl8j6ADganyvjxSnP5pa3yxmrkaeB-970l_-1v93sXX9Ll7BXZSd9PP0-PAF3EMTUDbv0Nk2bNZnS_MSzaxa7TT8TOD7TQvQXyOuO6w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Toxic+Injury+to+Muscle+Tissue+of+Rats+Following+Acute+Oximes+Exposure&rft.jtitle=Scientific+reports&rft.au=Ja%C4%87evi%C4%87%2C+Vesna&rft.au=Nepovimova%2C+Eugenie&rft.au=Ku%C4%8Da%2C+Kamil&rft.date=2019-02-06&rft.eissn=2045-2322&rft.volume=9&rft.issue=1&rft.spage=1457&rft_id=info:doi/10.1038%2Fs41598-018-37837-4&rft_id=info%3Apmid%2F30728420&rft.externalDocID=30728420
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon